论文部分内容阅读
同志们: 在举国上下、各条战线认真学习贯彻最近召开的“两会”精神和邓小平同志在南方几地的讲话,进一步加强改革开放和法制管理的新形势下,为了深入贯彻执行《药品管理法》和《新药审批办法》,促进我国新药的开发与研制,推广新药的临床应用,沟通药知医用、医知药情的信息;为了配合《中美关于保护知识产权谅解备忘录》的签署和1993年我国修改后的专利法的实施,探讨我国实行药品专利法后,医药行业所面临的新形势,卫生部委托《中国药房》杂志社召开了这次“全国首届新药与临床学术研讨会”。 这次会议的召开,得到了四川省、成都市党政及医药、卫生
Comrades: In order to thoroughly implement the “Drug Administration Law” in the new situation of all over the country, conscientiously study and implement the spirit of the “two sessions” held by Comrades in various fields and Comrade Deng Xiaoping’s speech in several places in the south, and further strengthen the reform, opening up and legal system administration, “And the” Measures for the Examination and Approval of New Drugs “to promote the development and development of new drugs in our country, promote the clinical application of new drugs, and communicate information on medical and medical knowledge. In line with the signing of the” Memorandum of Understanding on the Protection of Intellectual Property Rights between China and the United States “and 1993 The implementation of the revised patent law in our country in the year after the implementation of the Patent Law of Medicines in China and the new situation facing the pharmaceutical industry in China. The Ministry of Health commissioned the ”China Pharmacy“ magazine to hold the ”First National New Drug and Clinical Academic Seminar". The meeting was held in Sichuan Province, Chengdu, party and government and medicine, health